TOCOX-A Randomised, Double-Blind, Placebo-Controlled Trial of Rofecoxib (a COX-2-Specific Prostaglandin Inhibitor) for Prevention of Preterm Labor in Women at High Risk

&NA;

doi:10.1097/00132582-200512000-00020

TOCOX-A Randomised, Double-Blind, Placebo-Controlled Trial of Rofecoxib (a COX-2-Specific Prostaglandin Inhibitor) for Prevention of Preterm Labor in Women at High Risk

Obstetric Anesthesia Digest ◽

10.1097/00132582-200512000-00020 ◽

2005 ◽

Vol 25 (4) ◽

pp. 190

Author(s):

&NA;

Keyword(s):

High Risk ◽

Preterm Labor ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Prostaglandin Inhibitor ◽

Cox 2

Download Full-text

TOCOX?A randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/j.1471-0528.2005.00539.x ◽

2005 ◽

Vol 112 (6) ◽

pp. 725-730 ◽

Cited By ~ 44

Author(s):

Katie M. Groom ◽

Andrew H. Shennan ◽

Bryony A. Jones ◽

Paul Seed ◽

Phillip R. Bennett

Keyword(s):

High Risk ◽

Preterm Delivery ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Prostaglandin Inhibitor ◽

Cox 2

Download Full-text

TOCOX—a randomised double-blind placebo-controlled trial of rofecoxib (a COX-2 specific PG inhibitor) for the prevention of preterm delivery in high-risk women

Journal of Obstetrics and Gynaecology ◽

10.1080/718591797 ◽

2003 ◽

Vol 23 (sup1) ◽

pp. S19-S19 ◽

Cited By ~ 1

Author(s):

K. M. Groom ◽

A. H. Shennan ◽

B. A. Jones ◽

P. Seed ◽

P. R. Bennett

Keyword(s):

High Risk ◽

Preterm Delivery ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Risk Women ◽

Cox 2

Download Full-text

Faculty Opinions recommendation of MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718281739.793502937 ◽

2015 ◽

Author(s):

Jean-Francois Timsit

Keyword(s):

Critical Care ◽

High Risk ◽

Invasive Candidiasis ◽

Care Setting ◽

Controlled Trial ◽

Critical Care Setting ◽

Preemptive Therapy ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v68n0519 ◽

2007 ◽

Vol 68 (05) ◽

pp. 781-788 ◽

Cited By ~ 77

Author(s):

Robert L. Findling ◽

Thomas W. Frazier ◽

Eric A. Youngstrom ◽

Nora K. McNamara ◽

Robert J. Stansbrey ◽

...

Keyword(s):

Bipolar Disorder ◽

High Risk ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2009.01.015 ◽

2009 ◽

Vol 200 (6) ◽

pp. 627.e1-627.e10 ◽

Cited By ~ 29

Author(s):

Steven Thornton ◽

Thomas M. Goodwin ◽

Gorm Greisen ◽

Morten Hedegaard ◽

Joan-Carles Arce

Keyword(s):

Gestational Age ◽

Preterm Labor ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Threatened Preterm Labor ◽

Oxytocin Antagonist

Download Full-text

Double-Blind, Placebo-Controlled Trial of a Herpes Simplex Virus Type 2 Glycoprotein Vaccine in Persons at High Risk for Genital Herpes Infection

The Journal of Infectious Diseases ◽

10.1093/infdis/161.4.653 ◽

1990 ◽

Vol 161 (4) ◽

pp. 653-660 ◽

Cited By ~ 96

Author(s):

G. J. Mertz ◽

R. Ashley ◽

R. L. Burke ◽

J. Benedetti ◽

C. Critchlow ◽

...

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

High Risk ◽

Genital Herpes ◽

Herpes Simplex Virus Type ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Simplex Virus

Download Full-text

OC01.04: Aspirin versus placebo in pregnancies at high-risk of preterm pre-eclampsia: a multicentre, double-blind, placebo-controlled trial

Ultrasound in Obstetrics and Gynecology ◽

10.1002/uog.17573 ◽

2017 ◽

Vol 50 ◽

pp. 2-2 ◽

Cited By ~ 2

Author(s):

D. Rolnik ◽

D. Wright ◽

L. Poon ◽

N. O'Gorman ◽

A. Syngelaki ◽

...

Keyword(s):

High Risk ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue

American Journal of Obstetrics and Gynecology ◽

10.1067/mob.2000.95834 ◽

2000 ◽

Vol 182 (5) ◽

pp. 1173-1183 ◽

Cited By ~ 214

Author(s):

Roberto Romero ◽

Baha M. Sibai ◽

Luis Sanchez-Ramos ◽

Guillermo J. Valenzuela ◽

Jean-Claude Veille ◽

...

Keyword(s):

Receptor Antagonist ◽

Preterm Labor ◽

Controlled Trial ◽

Oxytocin Receptor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

European Heart Journal ◽

10.1093/eurheartj/ehs023 ◽

2012 ◽

Vol 33 (9) ◽

pp. 1142-1149 ◽

Cited By ~ 139

Author(s):

Maartje E. Visser ◽

Gilbert Wagener ◽

Brenda F. Baker ◽

Richard S. Geary ◽

Joanne M. Donovan ◽

...

Keyword(s):

High Risk ◽

Apolipoprotein B ◽

Controlled Trial ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Synthesis Inhibitor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090427.544389 ◽

2007 ◽

Author(s):

Torsten Reinheimer

Keyword(s):

Preterm Labor ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text